Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer

  • Technology appraisal guidance
  • TA227
  • Published: 

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): response to consultee, commentator and public comments on the ACD and comments from website consultation

This page was last updated: 08 March 2011